Navigation Links
Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
Date:10/23/2007

INDIANAPOLISThe Human Genome Sequencing Center at Baylor College of Medicine boosted its sequencing capabilities with an agreement to acquire seven additional Genome Sequencer FLX Systems from 454 Life Sciences, a Roche company.

With 10 Genome Sequencer FLX Systems, the Human Genome Sequencing Center will be in a unique position to apply 454 Life Sciences technologies to problems ranging from the deciphering of new genomes to the analysis of mutations associated with human diseases.

These instruments previously proved their capabilities in the arena of whole genome sequencing, said Richard Gibbs, Professor and Director of the Human Genome Sequencing Center at Baylor College of Medicine, a former member of the 454 Life Sciences Scientific Advisory Board until March 2007. Now they have demonstrated their potential role in large scale mutation detection.

To better understand genetic basis for disease - including cancer, heart disease, and asthma - genomic information from large numbers of individuals need to be analyzed in a rapid and cost-effective manner. Rapid DNA sequencing technologies allow researchers to identify all genetic changes when comparing healthy individuals to those with disease.

This purchase helps demonstrate that the GS FLX is a proven technology with nearly 100 published peer-review articles, said Lonnie Shoff, Senior Vice President of Molecular Diagnostics and Applied Science for Roche Diagnostics. We see the GS FLX being used in production sequencing due to the systems scalability to support both small and very large projects, along with the instruments durability, which allows it to be run continuously.

These efforts using the Genome Sequencer FLX are further enhanced by a collaboration with the Human Genome Sequencing Center at Baylor College of Medicine and another Roche company, Roche NimbleGen. Preliminary work from the collaboration was reported in Nature Methods this week, and
'/>"/>

Contact: Lori McLaughlin
lori.mclaughlin@roche.com
317-521-3112
Roche
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Grant of $7 million for Orissa Medical College from Japan
2. Orissa To Get New Medical Colleges Soon
3. Kottayam Medical College To be Upgraded
4. Kasturba Medical College Organizes CME- Orth 2005 From 4th To 6th November
5. Disadvantaged Students May Not Go In For College Education
6. Medical College Construction At Raichur Makes Slow Progress
7. Risk Attitudes And Consequences Of College Drinking
8. Call Of The Wild: Heard Of Spring Drinking? Ask The College Girls, Who Are Getting Freaked Out
9. Calcutta National Medical College Strike Continues Unabated
10. Medical Colleges, Confident of Meeting Standards Before 90-days deadline
11. Ignorance about AIDS rampart in Third of College Students: Chinese survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Garden State ... 2008, the result of a merger of five of the busiest urology practices ... could provide more cost-effective and higher quality care than they did individually. ...
(Date:8/31/2015)... ... ... Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as ... graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity ... his senior year. He was inducted into the National Honor Society as a sophomore, ...
(Date:8/31/2015)... ... ... Dr. Stewart Shofner of Shofner Vision Center explains what causes ... comprehensive eye examination can diagnose amblyopia. According to the National Eye Institute ... 2 to 3 out of every 100 children. , Dr. Shofner adds, “unless ...
(Date:8/31/2015)... Creek, CA (PRWEB) , ... August 31, 2015 ... ... national print and digital marketing communications company announced today that it has officially ... Fonzi, DP President, the new website and brand refresh are more closely aligned ...
(Date:8/31/2015)... ... August 31, 2015 , ... Three Bakers Gluten Free Bakery launched the redesign ... relevant and easy-to-find information on their offering of gluten-free breads and pizzas, living without ... important way for us to share information about our gluten free product offerings, but ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
... Global Breast ... Cancer Incidence, Mortality Rates, WASHINGTON, March 12 First ... for the Cure (R) Global Promise Fund at a,Capitol Hill ... its new strategy of funding culturally sensitive,sustainable education and outreach ...
... - Completed LogistiCare acquisition ... - Vanderbilt study released showing 81% success rate - Fourth ... and $6 million from social services ... segment, - Fourth quarter diluted earnings per share of $0.35, ...
... March 12 The following was,issued today by ... Forum (NQF) Implementation Conference on Care,Coordination and 2008 ... http://www.qualityforum.org ., March 26: Spring Membership ... NQF membership and leaders of the National Priorities,Partners, ...
... use ibuprofen for arthritis pain or other conditions while ... stroke undermine aspirins ability to act as an anti-platelet ... , In a cohort of patients seen by physicians ... patients were identified as taking both aspirin and ibuprofen ...
... Significantly Impact Patient Health and Financial ... Performance of Pharmaceutical Companies, NEW YORK and LONDON, ... billion per year and causing an,estimated 125,000 deaths per year ... the healthcare industry. Eularis has,responded to this problem with a ...
... finding shouldn,t keep physicians from using Avastin, researchers say , , ... drug Avastin can cause kidney damage by doing what it,s ... shows. , Avastin, whose generic name is bevacizumab, is the ... cancers by cutting off their blood supply. It does this ...
Cached Medicine News:Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 2Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 3Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 2Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 3Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 4Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 5Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 6Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 7Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 8Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 9Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 10Health News:National Quality Forum Spring Conference; Leaders in Healthcare Quality to Focus on National Priorities and Care Coordination 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 3Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 3Health News:Doctors See How Cancer Drug Can Damage Kidneys 2Health News:Doctors See How Cancer Drug Can Damage Kidneys 3
(Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with ... care management solutions powered by Qualcomm Life,s 2net™ ... to enable continuous care, informed interventions and better ... at Qualcomm Life,s annual Connect 2015 ...
(Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 ... Co., Ltd., and Purdue Pharma L.P. announced today that ... the development and commercialization of Eisai,s clinical candidate lemborexant ... Phase III clinical development for the treatment of insomnia. ... Eisai and Purdue Pharma will share the costs of ...
(Date:8/30/2015)... Switzerland , August 31, 2015 ... healthbank to deliver ... , the world,s first citizen-owned health data transaction platform, ... and Netcetera to engineer and bring to ...      (Logo: http://photos.prnewswire.com/prnh/20150828/261966) , "Our business model ...
Breaking Medicine Technology:Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4
... 31 Gen-Probe Incorporated,(Nasdaq: GPRO ) announced ... U.S.,clinical trial of its investigational APTIMA(R) assay to ... "Starting this highly complex, multi-center study was an ... Hull, the Company,s president and,chief operating officer. "Enrolling ...
... Three Key Lipids and Had ... CHICAGO, March 31 New data from ... multiple lipid problems, Abbott,s,ABT-335 combined with two commonly ... lipids -- LDL "bad",cholesterol, triglycerides and HDL "good" ...
Cached Medicine Technology:Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 2Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 3Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 4Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 5Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 2Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 3
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: